215 related articles for article (PubMed ID: 19339987)
21. Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis.
Niewold TB; Kariuki SN; Morgan GA; Shrestha S; Pachman LM
J Pediatr; 2010 Oct; 157(4):653-7. PubMed ID: 20605164
[TBL] [Abstract][Full Text] [Related]
22. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
Lin LH; Ling P; Liu MF
J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
[TBL] [Abstract][Full Text] [Related]
23. Genetic regulation of serum cytokines in systemic lupus erythematosus.
Kariuki SN; Niewold TB
Transl Res; 2010 Mar; 155(3):109-17. PubMed ID: 20171594
[TBL] [Abstract][Full Text] [Related]
24. Association of Osteopontin Gene Polymorphisms with Colorectal Cancer.
Kamal A; Darwish RK; Saad S; Salama M; El-Baradie TS; Mahmoud HG; Elshiwy Y
Cancer Invest; 2017 Feb; 35(2):71-77. PubMed ID: 28095066
[TBL] [Abstract][Full Text] [Related]
25. Osteopontin - a biomarker for organ damage in paediatric lupus?
Briggs TA
Arthritis Res Ther; 2013 Mar; 15(2):110. PubMed ID: 23472880
[TBL] [Abstract][Full Text] [Related]
26. Interferon alpha as a primary pathogenic factor in human lupus.
Niewold TB
J Interferon Cytokine Res; 2011 Dec; 31(12):887-92. PubMed ID: 21923413
[TBL] [Abstract][Full Text] [Related]
27. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
[TBL] [Abstract][Full Text] [Related]
28. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.
Kariuki SN; Franek BS; Kumar AA; Arrington J; Mikolaitis RA; Utset TO; Jolly M; Crow MK; Skol AD; Niewold TB
Arthritis Res Ther; 2010; 12(4):R151. PubMed ID: 20659327
[TBL] [Abstract][Full Text] [Related]
29. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
Robinson T; Kariuki SN; Franek BS; Kumabe M; Kumar AA; Badaracco M; Mikolaitis RA; Guerrero G; Utset TO; Drevlow BE; Zaacks LS; Grober JS; Cohen LM; Kirou KA; Crow MK; Jolly M; Niewold TB
J Immunol; 2011 Aug; 187(3):1298-303. PubMed ID: 21705624
[TBL] [Abstract][Full Text] [Related]
31. Interferon regulatory factors in human lupus pathogenesis.
Salloum R; Niewold TB
Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
[TBL] [Abstract][Full Text] [Related]
32. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
Niewold TB; Kelly JA; Flesch MH; Espinoza LR; Harley JB; Crow MK
Arthritis Rheum; 2008 Aug; 58(8):2481-7. PubMed ID: 18668568
[TBL] [Abstract][Full Text] [Related]
33. Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen.
Ghodke-Puranik Y; Imgruet M; Dorschner JM; Shrestha P; McCoy K; Kelly JA; Marion M; Guthridge JM; Langefeld CD; Harley JB; James JA; Sivils KL; Niewold TB
Cytokine; 2020 Aug; 132():154631. PubMed ID: 30685201
[TBL] [Abstract][Full Text] [Related]
34. Association of Osteopontin gene single nucleotide polymorphism with lupus nephritis.
Metwally RM; Hasan AS; R EG
Int J Rheum Dis; 2022 May; 25(5):571-575. PubMed ID: 35218609
[TBL] [Abstract][Full Text] [Related]
35. Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse.
Mathian A; Mouries-Martin S; Dorgham K; Devilliers H; Yssel H; Garrido Castillo L; Cohen-Aubart F; Haroche J; Hié M; Pineton de Chambrun M; Miyara M; Pha M; Rozenberg F; Gorochov G; Amoura Z
Ann Rheum Dis; 2019 Dec; 78(12):1669-1676. PubMed ID: 31570366
[TBL] [Abstract][Full Text] [Related]
36. [Osteopontin in systemic lupus erythematosus].
Kitagori K; Yoshifuji H
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):118-123. PubMed ID: 28603202
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus.
Rullo OJ; Woo JM; Parsa MF; Hoftman AD; Maranian P; Elashoff DA; Niewold TB; Grossman JM; Hahn BH; McMahon M; McCurdy DK; Tsao BP
Arthritis Res Ther; 2013 Jan; 15(1):R18. PubMed ID: 23343383
[TBL] [Abstract][Full Text] [Related]
38. Association between IFNA genotype and the risk of systemic lupus erythematosus.
Nakashima H; Matsuno S; Akahoshi M; Miyake K; Inoue Y; Tanaka Y; Ninomiya I; Shimizu S; Igawa T; Sadanaga A; Otsuka T; Harada M
Clin Rheumatol; 2005 Feb; 24(1):38-40. PubMed ID: 15674657
[TBL] [Abstract][Full Text] [Related]
39. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
Front Immunol; 2018; 9():1957. PubMed ID: 30210502
[No Abstract] [Full Text] [Related]
40. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 May; 44(5):602-6. PubMed ID: 15705633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
